DIA 2026 Global Annual Meeting

DIA 2026 Global Annual Meeting

arrow_back View All Dates

8:00am EDT

#500: Transforming Obesity Patient Care: Past, Present, and Future Innovation in the Age of GLP-1 Therapies 114

9:15am EDT

#501 IT: Weave Bio Innovation Theater: Threading AI Throughout the Drug Development Lifecycle - An Enterprise Lens Innovation Theater 3 #502 IT: IQVIA Innovation Theater: From Insight to Impact - Leveraging Patient Experience Data Through Technology and AI Innovation Theater 1 #503 IT: Parexel Innovation Theater: Human-Centered AI - A Dual-Layer Model for Clinical Research Excellence Innovation Theater 2

10:15am EDT

#504: From Conventional to Intelligent: Redefining Pharmacovigilance with AI and Global Collaboration 118AB #506: From Barriers to Bridges: Unlocking Research Potential in Primary Care 108B #507: Paying Fair: Regulatory and Ethical Challenges in Research Participant Compensation 107AB #505: Agility Unlocked: How Mixed FSP/FSO Models Enhance Efficiency and Facilitate the Transition from FSO to FSP Outsourcing 108A #515: Leveraging Federated AI and Open Data to Transform Oncology Research and Development 112AB #510: The Trials and Virtues of Founder Led Selling: Rapid Discovery and Validation of Product-Market Fit for ClinTech 103A #513: Advancing Chronic Disease Development: Insights from FDA, EMA, PMDA, and MHRA 201AB #508: How Standardized Protocol Data Plus AI Power Patient Centric Studies 111AB #509: Integrating Artificial Intelligence and Real-World Evidence: FDA's Framework for Advancing Medical Product Development 109AB #511: AI Risk Scores and Regulatory Forks: Diagnose Your Software’s Regulatory Fate 203AB #512: Enhanced Analytical Procedure Development: Principles, Prior Knowledge, and Change Management 202AB #516: Modernizing Nonclinical Safety Assessment: FDA and EMA Roadmaps to Reduce Animal Testing 115C #517: Navigating the New FDA: Insights from Former FDA Chief of Staffs 204AB #519.1: European Integration in Times of Geopolitical Crisis: Supporting Ukraine’s EU Accession and Building Resilient Public Institutions 105AB #514: Innovation Gridlock: When Misaligned Policies Threaten Progress for Patients 115AB #518: Next Generation Clinical Trial Quality Assurance Using Advanced Analytics 117 #519: Patient Registries: Basket Trial or Basket Case? 116

11:30am EDT

#520 POS: Professional Poster Session II Exchange

11:40am EDT

#521 CH: Achieving Representative Enrollment in Phase 3 Lupus Clinical Trials: A Case Study Content Hub

11:45am EDT

#522 IT: Artos, Inc Innovation Theater: AI Isn't About Generating Documents, it's About Generating Data Innovation Theater 2 #521.1 SS: Spark Stage: Patient Appreciation Session: Celebrating the Patient Voice Spark Stage #523 IT: Syneos Health Innovation Theater: More Doesn't Guarantee Better - Why AI Success Depends on Organizational Agility, Not Just the Tech Innovation Theater 1

12:25pm EDT

#524 IT: Vivpro Corporation Innovation Theater: AI in Action - Scaling Regulatory Document Generation Across R&D Innovation Theater 2 #525 IT: Yseop Innovation Theater: Design Regulatory Grade AI - Enable Scalable, Consistent Workflows Across Document Types Innovation Theater 1

12:30pm EDT

#526 RT: Roundtable Discussion: FDA Public Posting of Complete Response Letters: A Year in Review, Trends, and Impact Analysis Zone A

1:05pm EDT

#527 IT: Certara Innovation Theater: LLM-Driven Submissions: From Data Preparation to eCTD Innovation Theater 1

1:45pm EDT

#528: Suffix or Superfluous? Evaluating FDA’s Biologics Naming Convention 118AB #529: Early Outcomes and Strategic Learnings from the DIA Obesity Consortium’s Initial Collaborative Phase 108A #531: Tolerability in Immuno-Oncology: Patient Experience as a Core Element of Clinical Trials 107AB #530: The Synthetic AI Patient Persona: Augmenting Patient Centricity in Clinical Trials 108B #532: Applied Innovation for Patients: Implementing AI, Cloud, and Data in Regulatory Science 109AB #533: Is Your AI Ready to Scale? Build the Governance Backbone for Reliable Innovation and Trust 111AB #535: Unlock AI's Full Potential: The Power of FAIR Data 119AB #534: The Best Pitch Advice I Ever Got: How to Nail Main Stage Talks, Pitch Decks, and Any Talk of a Lifetime 103A #536: Project Management as a Catalyst for Enterprise Transformation 202AB #537: EMA Town Hall 204AB #538: Innovations in Drug Review: A Global Perspective 201AB #540: Regulators Approach to Address Drug Shortages 115C #541: Taiwan Town Hall: Strategies to Promote Medicine Supply Resilience 112AB #539: Labeling as a Strategic Asset: Advancing Patient Voice and Creating Value Through Meaningful Product Communication 115AB #542: Quality by Design Revolution: Is There Still a Place for Traditional Clinical Trial Functions? 117 #543: Global Regulatory Perspectives on Bayesian Design and Analysis Informing Regulatory Decision Making 116

3:15pm EDT

#546 IT: Collate Innovation Theater: A Thousand Document Types - An AI Platform Approach to Document Authoring and Intelligence Adopted by Global Enterprises Innovation Theater 1 #544 RT: Roundtable Discussion: Is Your AI Ready to Scale? Build the Governance Backbone for Reliable Innovation and Trust Zone B #545 RT: Roundtable Discussion: Regulators Approach to Address Drug Shortages Zone A

4:15pm EDT

#547: Increasing Vigilance Transparency: When is the Right Time to Publish Safety Signals? 118AB #548: Clinical Research Training for Community Cancer Centers: A Pilot to Extend Clinical Trials into Diverse Catchment Areas 108A #549: Reimagining Site Source: Optimizing Clinical Trial Execution for Sponsors, Sites, and Patients 108B #550: Evolving Artificial Intelligence Regulatory Landscape in Drug Development Across US and EU 109AB #551: Operationalizing Large Language Models in Drug Development 111AB #552: Optimizing the Content Ecosystem Through Lean Authoring: A Framework to Meet Regulatory Expectations and Prepare to Automate 105AB #563: Oncology Pathways Under Pressure: From CAR-T Access Today to Longevity-Driven Care Tomorrow 107AB #553: Latest in Combination Product Industry Trends: Development and Submission Strategies for Success 203AB #554: Reverse Pitches: How Pharma Actually Buys 103A #555: Adapting Regulatory Frameworks to Address Mass Distribution of Unapproved or Unauthorized Medicines 118C #556: Access Consortium Town Hall 201AB #557: Advancing Global Regulatory Harmonization for Cell and Gene Therapies: Enhancing Access and Innovation 115AB #560: Novel Endpoints, Biomarkers, and Digital Tools: Strategies for Regulatory Acceptance and Scientific Alignment 119AB #559: China Town Hall 202AB #558: Advancing Pediatric Drug Development in Asia through Real-World Evidence and Regulatory Innovation 115C #561: Unlocking Transformative Value: AI and Advanced Analytics in Good Clinical Practice and Good Pharmacovigilance Practice Quality Assurance 117 #562: Leveraging Real-World Evidence and External Controls in Clinical Trials of Rare Outcomes/Diseases: Statistical Innovation and Novel Applications 116

DIA 2026 Global Annual Meeting

Register to attend